Culture medium for breeding or culturing tumor stem cell spheres and application of culture medium
By using a specific combination of serum-free medium formula, including a variety of growth factors and lipidic acids, the problem of poor homogeneity and specificity of tumor stem cell spheres was successfully solved, and efficient tumor stem cell sphere culture was achieved, suitable for multi-field research .
Patent Information
- Application Number
- CN202411076647.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to effectively enrich and culture homogeneous tumor stem cell spheres, which have poor spheroid specificity and heterogeneity problems, which affect large-scale culture and application.
Provide a serum-free medium formula, including transforming growth factor TGFβ1, vascular endothelial growth factor VEGF, platelet-derived growth factor PDGF, myristic acid, oleic acid, palmitic acid, linolenic acid, bovine serum albumin, alkaline fiber Growth factor bFGF, epidermal growth factor EGF, glutamic acid, proline, tryptophan, ammonium molybdate, stannous chloride, silver nitrate, potassium iodide and other components, combined with DMEM/F12 as the base medium, form tumor stem cell spheres .
It significantly improves the enrichment rate of tumor stem cells, enhances the expression of tumor stem cell characteristics, ensures the homogeneity of the sphere, simplifies the culture process, reduces the cost, and is suitable for cell biology and pharmacy research.
Smart Images

Figure CN119082038A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of cell biology, and relates to a culture medium for cultivating or culturing tumor stem cell spheres and its application, and specifically to a culture medium formula for cultivating or culturing tumor stem cell spheres and its preparation method, and a culture scheme for culturing tumor stem cells and / or tumor stem cell spheres using the culture medium. Background Art
[0002] Cancer stem cells (CSCs) play an important role in the occurrence, development, and deterioration of cancer. They are a unique subpopulation of cancer cells. These cells have the same characteristics as normal stem cells, namely the ability to self-renew and differentiate. They have the ability to continuously expand the cancer cell population and can differentiate into various cancer cell subpopulations, thereby continuously producing offspring and heterogeneous cancer cells in tumor tissues, continuously promoting the malignant growth of tumors and promoting invasion into neighboring tissues. At present, in order to explore in detail the role of cancer stem cells in the development of cancer, as well as the effects of exposure to various environmental pollutants with carcinogenic risks on cancer stem cells, a stable and mature cancer stem cell research model is urgently needed.
[0003] At present, a common method for enriching tumor stem cells is serum-free screening, through which stem cells can be enriched to form a three-dimensional spherical structure, but there is no efficient and mature formula for specific serum-free culture components. Although tumor stem cell spheres can be formed in previous studies, there are two main problems: one is the problem of poor sphere specificity, that is, the characteristics related to each tumor stem cell cannot be significantly enriched; the other is the great heterogeneity, that is, the shape and size are very uneven, which makes it impossible to culture and apply them on a large scale. Summary of the invention
[0004] Based on this, the main purpose of the present invention is to provide a serum-free culture medium formula and a corresponding culture method that can enrich tumor stem cells to a great extent and ensure the homogeneity of tumor stem cell sphere formation.
[0005] In order to achieve the above object, the present invention relates to the following aspects:
[0006] On the one hand, the present invention provides a culture medium for developing or culturing tumor stem cell spheres (CSCs Complete), which is preferably used for culturing tumor stem cell spheres, characterized in that the culture medium comprises TVP, MOPL, a Chinese herbal medicine extract, and lipid additives, protein additives, amino acid additives, and inorganic salt additives;
[0007] The TVP is a combination of transforming growth factor TGFβ1, vascular endothelial growth factor VEGF, and platelet-derived growth factor PDGF.
[0008] The above MOPL is a combination of myristic acid, oleic acid, palmitic acid and linolenic acid.
[0009] The lipid additives include cholesterol and tocopherol acetate;
[0010] The above-mentioned protein additives include bovine serum albumin, basic fibroblast growth factor bFGF, and epidermal growth factor EGF;
[0011] The amino acid additives include glutamic acid, proline, and tryptophan; the inorganic salt additives include ammonium molybdate, stannous chloride, silver nitrate, and potassium iodide.
[0012] In the culture medium of the present invention, the volume ratio of the TVP to the culture medium is 3%-5%. In the TVP,
[0013] The concentration of transforming growth factor TGFβ1 is 1-10 ng / mL, preferably 5-7 ng / mL;
[0014] The concentration of vascular endothelial growth factor VEGF is 100-200 μg / mL, preferably 120-150 μg / mL;
[0015] The concentration of platelet-derived growth factor PDGF is 40-80 μg / mL, preferably 50-65 μg / mL.
[0016] In the culture medium of the present invention, the volume ratio of the above-mentioned MOPL to the above-mentioned culture medium is 0.008%-0.01%. In the above-mentioned MOPL,
[0017] The concentration of myristic acid is 7-15 mg / L, preferably 8-12 mg / L;
[0018] The concentration of oleic acid is 9-13 mg / L, preferably 10-12 mg / L;
[0019] The concentration of palmitic acid is 8-15 mg / L, preferably 9-12 mg / L;
[0020] The concentration of linolenic acid is 6-18 mg / L, preferably 8-14 mg / L.
[0021] In the culture medium of the present invention, the volume ratio of the Chinese herbal medicine extract to the culture medium is 0.1%.
[0022] Among them, the above-mentioned Chinese medicine extracts are resveratrol, tanshinone and magnolol.
[0023] Among them, the above-mentioned Chinese medicine extracts
[0024] The concentration of the resveratrol is 10-1000 μM, preferably 200-500 μM;
[0025] The above-mentioned tanshinone is 1-100 μM, preferably 50-80 μM;
[0026] The concentration of magnolol is 3-10 mM, preferably 5-8 mM.
[0027] In the culture medium according to the present invention,
[0028] The volume ratio of the lipid additive to the culture medium is 0.001%-0.01%, preferably 0.003%-0.005%; wherein the concentration of cholesterol is 200-300 mg / L (preferably 230-250 mg / L), and the concentration of tocopherol acetate is 50-100 mg / L (preferably 60-70 mg / L);
[0029] The volume ratio of the above protein additive to the above culture medium is 2%-8%, preferably 3%-5%; wherein the concentration of bovine serum albumin is 200-350 mg / mL (preferably 240-270 mg / mL), the concentration of basic fibroblast growth factor bFGF is 3-7 mg / mL (preferably 4.8-6 mg / mL), and the concentration of epidermal growth factor EGF is 20-50 μg / mL (preferably 20-38 μg / mL);
[0030] The volume ratio of the amino acid additive to the culture medium is 0.02%-0.2%, preferably 0.08%-0.12%; wherein the concentration of glutamic acid is 5-20mM (preferably 8-12mM), the concentration of proline is 5-20mM (preferably 8-12mM), and the concentration of tryptophan is 5-20mM (preferably 8-12mM);
[0031] The volume ratio of the above-mentioned inorganic salt additives to the above-mentioned culture medium is 0.05%-0.08%, preferably 0.05%-0.4%; wherein the concentration of ammonium molybdate is 0.2-2 mg / L (preferably 1-1.5 mg / L), the concentration of stannous chloride is 0.05-0.8 mg / L (preferably 0.1-0.3 mg / L), the concentration of silver nitrate is 0.03-0.39 mg / L (preferably 0.08-0.2 mg / L), and the concentration of potassium iodide is 0.05-0.9 mg / L (preferably 0.05-0.2 mg / L).
[0032] In the culture medium according to the present invention,
[0033] (1) The lipid additive further comprises: one or more selected from the group consisting of arachidonic acid (1-6 mg / L, preferably 2-4 mg / L), linoleic acid (7-15 mg / L, preferably 9-12 mg / L), and stearic acid (4-13 mg / L, preferably 10-12 mg / L);
[0034] (2) The above-mentioned protein additive further comprises: a combination of one or more selected from reduced glutathione (0.005-0.05 mg / mL, preferably 0.01-0.03 mg / mL), insulin (0.5-0.8 mg / mL, preferably 0.1-0.3 mg / mL), and transferrin (50-100 μg / mL, preferably 50-70 μg / mL);
[0035] (3) The amino acid additive further comprises: a combination of one or more selected from glycine (5-20 mM, preferably 8-12 mM), alanine (5-20 mM, preferably 8-12 mM), asparagine (5-20 mM, preferably 8-12 mM), and aspartic acid (5-20 mM, preferably 8-12 mM); and / or
[0036] (4) The above-mentioned inorganic salt additives also include: manganese sulfate (0.05-0.5 mg / L, preferably 0.1-0.2 mg / L), sodium silicate (100-180 mg / L, preferably 120-150 mg / L), ammonium metavanadate (0.1-1 mg / L, preferably 0.4-0.68 mg / L), nickel sulfate (0.05-1 mg / L, preferably 0.1-0.2 mg / L), aluminum chloride (0.5-3 mg / L, preferably 1-2.2 mg / L), barium acetate (1-5 mg / L, preferably 2-3 mg / L), potassium bromide (0.01-1 mg / L, preferably 0. Selected as 0.05-0.15mg / L), cadmium chloride (2-10mg / L, preferably 2-5mg / L), cobalt chloride (1-7mg / L, preferably 2-4mg / L), chromium chloride (0.1-1mg / L, preferably 0.2-0.5mg / L), sodium fluoride (3-10mg / L, preferably 4-6mg / L), germanium dioxide (0.2-1mg / L, preferably 0.4-0.8mg / L), rubidium chloride (0.5-5mg / L, preferably 1-3mg / L), zirconium oxychloride (2-10mg / L, preferably 2-5mg / L) One or more combinations thereof.
[0037] The culture medium for tumor stem cell sphere cultivation or culturing of the present invention further comprises DMEM / F12 as a basal culture medium, and the volume ratio of DMEM / F12 to the above-mentioned culture medium for tumor stem cell sphere cultivation or culturing is 70%-90%, preferably 90%.
[0038] On the other hand, a method for culturing or cultivating tumor stem cell spheres is characterized by culturing tumor stem cells and / or tumor stem cell spheres using the above-mentioned culture medium.
[0039] The above method comprises the following steps:
[0040] (1) To form tumor stem cell spheres, the initial seeding density of tumor cells was 2×10 3 / mL-1×10 4 / mL, preferably 5×10 3 / mL-9×10 3 / mL.
[0041] (2) The amount of the above-mentioned tumor stem cell sphere culture medium used is 0.2-0.5 mL / cm 2 , preferably 0.32-0.4 mL / cm 2 .
[0042] (3) The number of days for the emergence of tumor stem cell spheres by culture or culturing with a tumor stem cell sphere culture medium is 10-16 days, preferably 12-14 days.
[0043] (4) The tumor stem cell spheres are in a suspended state, and the culture medium for tumor stem cell sphere cultivation or culturing is replenished every 2-3 days, preferably 0.5-1 mL.
[0044] Specifically involved are the following plans:
[0045] As one aspect of the present invention, a culture scheme for tumor stem cell spheres is provided, which includes two parts: a basic scheme and a preferred scheme for preparing a culture medium for cultivating or culturing tumor stem cell spheres, and a method for culturing tumor cells to form tumor stem cell spheres using the culture medium.
[0046] In one aspect of the present invention, a culture medium for culturing tumor stem cells into tumor stem cell spheres is provided, wherein the culture medium (CSCs Complete) is composed of a basal culture medium (CSCs Basal) and a culture medium supplement (CSCs Sup).
[0047] The basal culture medium used is DMEM / F12 culture medium (Gibco, 21331020), and its volume ratio relative to the culture medium for tumor stem cell sphere cultivation or culture (i.e., total culture medium) is 70%-90%, preferably 90%;
[0048] The above-mentioned culture medium additives are composed of four major categories of substances: lipid additives (L Sup), protein additives (P Sup), amino acid additives (A Sup), and inorganic salt additives (S Sup). Each component has a different suitable concentration range and preferred concentration range.
[0049] Specifically, in a preferred embodiment of the present invention, the lipid culture medium additives include: arachidonic acid (1-6 mg / L, preferably 2-4 mg / L), cholesterol (200-300 mg / L, preferably 230-250 mg / L), tocopherol acetate (50-100 mg / L, preferably 60-70 mg / L), linoleic acid (7-15 mg / L, preferably 9-12 mg / L), stearic acid (4-13 mg / L, preferably 10-12 mg / L), and MOPL.
[0050] The above MOPL includes: myristic acid (7-15 mg / L, preferably 8-12 mg / L), oleic acid (9-13 mg / L, preferably 10-12 mg / L), palmitic acid (8-15 mg / L, preferably 9-12 mg / L), and linolenic acid (6-18 mg / L, preferably 8-14 mg / L).
[0051] Among them, protein culture medium additives include: bovine serum albumin (200-350 mg / mL, preferably 240-270 mg / mL), reduced glutathione (0.005-0.05 mg / mL, preferably 0.01-0.03 mg / mL), insulin (0.5-0.8 mg / mL, preferably 0.1-0.3 mg / mL), transferrin (50-100 μg / mL, preferably 50-70 μg / mL), epidermal growth factor EGF (20-50 μg / mL, preferably 20-38 μg / mL), and TVP.
[0052] The above-mentioned TVP includes: transforming growth factor TGFβ (1-10 ng / mL, preferably 5-7 ng / mL), vascular endothelial growth factor VEGF (100-200 μg / mL, preferably 120-150 μg / mL), and platelet-derived growth factor PDGF (40-80 μg / mL, preferably 50-65 μg / mL).
[0053] Among them, amino acid culture medium additives include: glycine (5-20mM, preferably 8-12mM), alanine (5-20mM, preferably 8-12mM), asparagine (5-20mM, preferably 8-12mM), aspartic acid (5-20mM, preferably 8-12mM), glutamic acid (5-20mM, preferably 8-12mM), proline (5-20mM, preferably 8-12mM), tryptophan (5-20mM, preferably 8-12mM).
[0054] Among them, inorganic salt culture medium additives include: manganese sulfate (0.05-0.5 mg / L, preferably 0.1-0.2 mg / L), sodium silicate (100-180 mg / L, preferably 120-150 mg / L), ammonium molybdate (0.2-2 mg / L, preferably 1-1.5 mg / L), ammonium metavanadate (0.1-1 mg / L, preferably 0.4-0.68 mg / L), nickel sulfate (0.05-1 mg / L, preferably 0.1-0.2 mg / L), stannous chloride (0.05-0.8 mg / L, preferably 0.1-0.3 mg / L), aluminum chloride (0.5-3 mg / L, preferably 1-2.2 mg / L), silver nitrate (0.03-0.39 mg / L, preferably 0.08-0.2 mg / L), barium acetate ( 1-5mg / L, preferably 2-3mg / L), potassium bromide (0.01-1mg / L, preferably 0.05-0.15mg / L), cadmium chloride (2-10mg / L, preferably 2-5mg / L), cobalt chloride (1-7mg / L, preferably 2-4mg / L), chromium chloride (0.1-1mg / L, preferably 0.2-0.5mg / L), sodium fluoride (3-10mg / L, preferably 4-6mg / L), potassium iodide (0.05-0.9mg / L, preferably 0.05-0.2mg / L), germanium dioxide (0.2-1mg / L, preferably 0.4-0.8mg / L), rubidium chloride (0.5-5mg / L, preferably 1-3mg / L), zirconium oxychloride (2-10mg / L, preferably 2-5mg / L).
[0055] The above-mentioned Chinese herbal extracts include: resveratrol (10-1000μM, preferably 200-500μM), tanshinone (1-100μM, preferably 50-80μM), and magnolol (3-10mM, preferably 5-8mM), wherein the values in brackets are the preferred concentrations for preparing a mixture of each Chinese herbal extract, and the addition ratio of the Chinese herbal extract is 0.05%-0.1% of the total culture medium volume.
[0056] Furthermore, each type of media additive has a different dilution ratio.
[0057] Specifically, lipid culture medium additives account for 0.001%-0.01% of the volume ratio of the above-mentioned culture medium, preferably 0.003%-0.005%; protein culture medium additives account for 5%-20% of the volume ratio of the above-mentioned culture medium, preferably 6%-10%; amino acid culture medium additives account for 0.02%-0.2% of the volume ratio of the above-mentioned culture medium, preferably 0.08%-0.12%; inorganic salt culture medium additives account for 0.05%-0.08% of the volume ratio of the above-mentioned culture medium, preferably 0.05%-0.4%.
[0058] Another aspect of the present invention provides a method for culturing tumor stem cell spheres using the above culture medium.
[0059] Specifically, to form tumor stem cell spheres, the starting seeding density required is 2×10 3 / mL-1×10 4 / mL, preferably 5×10 3 / mL-9×10 3 / mL.
[0060] The amount of culture medium used for tumor stem cell sphere cultivation or culture is 0.2-0.5mL / cm 2 , preferably 0.32-0.4 mL / cm 2 .
[0061] The culture medium for tumor stem cell sphere cultivation or culture needs to be used for 10-16 days, preferably 12-14 days. To maintain the suspension state of tumor stem cell spheres, a certain volume of culture medium for tumor stem cell sphere cultivation or culture is added every 2-3 days, preferably 0.5-1 mL.
[0062] A series of characterizations of the formed tumor stem cell spheres demonstrated the specificity of the culture medium for tumor stem cell enrichment. The characterization methods specifically include: 1) detection of pluripotency genes including NANOG, OCT4, SOX2, etc.; 2) detection of specific leukocyte differentiation antigens, such as CD133, CD166, CD117, etc., encoding genes of specific surface marker proteins; 3) detection of the epithelial-mesenchymal transition (EMT) process that marks tumor cell invasion and metastasis.
[0063] Compared with the prior art, the tumor stem cell sphere culture scheme of the present invention has at least one or part of the following beneficial effects:
[0064] The culture medium formula for the cultivation or culture of tumor stem cell spheres provided by the present invention comprises key protein factors for improving the stemness of tumor cells, such as transforming growth factor TGFβ1, vascular epithelial growth factor VEGF, platelet-derived growth factor PDGF, and fatty acids such as myristic acid, oleic acid, palmitic acid linolenic acid, etc., which improve the fatty acid oxidation level of the culture environment, and also comprises a large number of nutrients such as lipids, proteins, amino acids, and inorganic salts that are conducive to the enrichment of tumor stem cells, promotes the intracellular metabolism mode to be conducive to enhancing fatty acid oxidation, and the stemness of tumor stem cells is enhanced, and the formation of specific tumor stem cell spheres is guaranteed to a great extent. Therefore, compared with the existing simple culture medium, the culture medium can significantly improve the enrichment rate of tumor stem cells, enhance the expression of tumor stem cell characteristics, and ensure the homogeneity of the spheres.
[0065] The culture medium formula for the cultivation or culture of tumor stem cell spheres provided by the present invention contains three Chinese herbal extract components, namely, resveratrol, tanshinone and magnolol. Due to their anti-inflammatory and antioxidant effects, they improve the environment of the culture medium, allowing tumor stem cells to divide and proliferate in a more stable microenvironment to form tumor stem cell spheres. In addition, the formed tumor stem cell spheres can be maintained in the culture medium for a longer time with optimal biological activity, which is convenient for subsequent research and experiments.
[0066] The method for culturing tumor stem cell spheres provided by the present invention is simple and easy to operate. It only requires supplementary culture at a certain time interval during the culture process. At the same time, only conventional cell culture tools are needed to maintain the tumor stem cells in a suspended state, thereby achieving the purpose of enriching into spheres. The ultra-low adsorption tools required in the traditional method to maintain the suspended state of the spheres are abandoned. Such ultra-low adsorption tools are not only difficult to purchase, but also expensive, which greatly limits the culture scale of tumor stem cell spheres and greatly increases the culture cost. Therefore, the present invention reduces the culture cost on the basis of simplified operation.
[0067] The culture scheme of tumor stem cell spheres provided by the present invention can be applied to research fields such as cell biology, pharmacy, toxicology, etc. in a simple, efficient and low-cost manner. It can provide a model reference for detailed exploration of the role of tumor stem cells in the occurrence, development and deterioration of cancer and the development of possible anticancer drugs, or reveal the carcinogenic mechanism of environmental carcinogenic pollutants with tumor stem cells as the hub.
[0068] The term "cancer stem cells" refers to a type of cell in a tumor that has stem cell characteristics, and has high proliferation and self-renewal capabilities and can differentiate into heterogeneous tumor cells (ie, cell stemness).
[0069] The term "ROS content" refers to the content of reactive oxygen species (ROS) in cells and is an important indicator for measuring the level of cellular oxidation in the system.
[0070] The term "suspended state" includes a state in which the cells in the culture medium are not in contact with the wall of the culture container and / or a state in which the cells can be easily detached from the wall of the culture container by refluxing the culture medium without the aid of a tool.
[0071] The term "EMT" refers to the process of epithelial-mesenchymal transformation, which is regulated by multiple genes. The higher the expression of EMT genes, the stronger the metastasis and invasion ability of tumor cells. It is the key data and basis for measuring tumor cell metastasis and invasion. For the convenience of explanation, it is also referred to as epithelial-mesenchymal transformation in this article. BRIEF DESCRIPTION OF THE DRAWINGS
[0072] Figure 1 Microscope (A) and scanning electron microscope (SEM) (B) morphology images of the lung tumor stem cell spheroids shown in the example (basic scheme) of the present invention.
[0073] Figure 2 This is a graph showing changes in pluripotency gene expression obtained after real-time fluorescence quantitative PCR detection in an embodiment of the present invention.
[0074] Figure 3 This is a graph showing changes in leukocyte differentiation antigen gene expression obtained after real-time fluorescence quantitative PCR detection in an embodiment of the present invention.
[0075] Figure 4 This is a diagram of gene expression changes during the epithelial-mesenchymal transition (EMT) process obtained after real-time fluorescence quantitative PCR detection in an embodiment of the present invention.
[0076] Figure 5 The figure is the result of immunofluorescence staining of lung tumor stem cell spheres using NANOG protein antibody in the example of the present invention.
[0077] Figure 6 This is the result of immunofluorescence staining of lung tumor stem cell spheres using OCT4 protein antibody in the examples of the present invention.
[0078] Figure 7 The results of immunofluorescence staining of lung tumor stem cell spheres using SOX2 protein antibodies in the examples of the present invention are shown.
[0079] Figure 8 The comparison results of cell morphology in Example (A) of the present invention and the prior art solution (B) are shown.
[0080] Fig. 9 The figure is a comparison result of the expression of characteristic genes of lung tumor stem cells in the embodiment of the present invention and the existing scheme.
[0081] Fig.10 The figure is a comparison result of the proliferation activity of lung tumor stem cells in the embodiment of the present invention and the existing solution.
[0082] Fig.11 Graph showing the effect of the presence or absence of MOPL on the morphology of tumor stem cell spheres in the examples of the present invention.
[0083] Fig.12 Graph showing the effect of the presence or absence of MOPL on the fatty acid oxidation level in lung cancer stem cell spheres in the example of the present invention.
[0084] Fig.13 The figure shows the effect of the presence or absence of TVP on the morphology of tumor stem cell spheres in the examples of the present invention.
[0085] Fig.14 The figure shows the comparison result of the effect of the presence or absence of TVP on the expression of lung tumor stem cell characteristic genes in the examples of the present invention.
[0086] Fig.15 The present invention demonstrates the influence of the presence or absence of various Chinese medicine extracts on the expression level of inflammatory factors in the culture environment.
[0087] Fig.16 The present invention shows the influence of the presence or absence of each Chinese medicine extract on the ROS content in the culture environment. DETAILED DESCRIPTION
[0088] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the technical solutions of the present invention are further explained below through specific implementation methods, and the technical effects produced by the present invention are clearly and completely described with reference to the accompanying drawings, so as to fully understand the application and effects of the present invention, but the implementation methods of the present invention are not limited to this.
[0089] The following experimental methods are conventional methods unless otherwise specified, and the materials used can be obtained from commercial companies or prepared by known preparation methods unless otherwise specified.
[0090] Example 1: Preparation of a special culture medium for tumor stem cell formation / cultivation
[0091] 1. Preparation of the basic culture medium
[0092] (1) Preparation of lipid additives: Cholesterol (248 mg / L) and tocopherol acetate (60 mg / L) were dissolved and mixed in a 0.3%-0.5% BSA (ultrapure) aqueous solution to a volume ratio of 0.005%; MOPL (linolenic acid (8 mg / L), myristic acid (15 mg / L), oleic acid (9 mg / L), palmitic acid (15 mg / L)) was dissolved and mixed, and the prepared lipid additives were added to the basal culture medium at a volume ratio of 0.008% respectively;
[0093] (2) Preparation of protein additives: Dissolve bovine serum albumin (270 mg / mL), basic fibroblast growth factor bFGF (6 mg / mL), and epidermal growth factor EGF (35 μg / mL) in ultrapure water and mix them to a volume ratio of 5%; dissolve TVP (transforming growth factor TGFβ1 (7 ng / mL), vascular endothelial growth factor VEGF (120 μg / mL), and platelet-derived growth factor PDGF (50 μg / mL)) and mix them to a volume ratio of 5% and add the prepared protein additives to the basal culture medium respectively;
[0094] (3) Preparation of amino acid additives: Dissolve glutamic acid (12 mM), proline (12 mM), and tryptophan (12 mM) in ultrapure water and mix well, and add the prepared amino acid additives into the basal culture medium at a volume ratio of 0.08%;
[0095] (4) Preparation of inorganic salt additives: Dissolve ammonium molybdate (1.5 mg / L), stannous chloride (0.3 mg / L), silver nitrate (0.2 mg / L), and potassium iodide (0.2 mg / L) in ultrapure water and mix well, and add the prepared inorganic salt additives into the basal culture medium at a volume ratio of 0.05%;
[0096] (5) Preparation of Chinese herbal medicine extract: Resveratrol (250 μM), tanshinone (60 μM), and magnolol (6 mM) were dissolved and mixed in DMSO, and the prepared Chinese herbal medicine extract was added into the basal culture medium at a volume ratio of 0.1%;
[0097] (6) The above-mentioned culture medium additives and Chinese herbal medicine extracts are mixed with 90% by volume of basal culture medium (CSCs Basal), and the basic culture medium solution is prepared.
[0098] In order to obtain better culture effects, the inventors further optimized the above basic scheme as shown below.
[0099] 2. Preparation of culture medium optimization plan
[0100] (1) Preparation of lipid additives: Dissolve arachidonic acid (1.5 mg / L), cholesterol (248 mg / L), tocopherol acetate (60 mg / L), linoleic acid (12 mg / L), stearic acid (11.8 mg / L) and the like in 0.3%-0.5% BSA (ultrapure) aqueous solution and mix them to a volume ratio of 0.005%; dissolve MOPL (linolenic acid (8 mg / L), myristic acid (15 mg / L), oleic acid (9 mg / L), palmitic acid (15 mg / L)) and mix them to a volume ratio of 0.008% and add the prepared lipid additives to the basal culture medium respectively;
[0101] (2) Preparation of protein additives: Dissolve bovine serum albumin (270 mg / mL), reduced glutathione (0.03 mg / mL), insulin (0.3 mg / mL), transferrin (70 μg / mL), basic fibroblast growth factor bFGF (6 mg / mL), epidermal growth factor EGF (35 μg / mL) and the like in ultrapure water and mix them evenly to a volume ratio of 5%; dissolve TVP (transforming growth factor TGFβ1 (7 ng / mL), vascular endothelial growth factor VEGF (120 μg / mL), platelet-derived growth factor PDGF (50 μg / mL)) and mix them evenly, and add the prepared protein additives into the basal culture medium at a volume ratio of 5% respectively;
[0102] (3) Preparation of amino acid additives: Dissolve glycine (12 mM), alanine (12 mM), asparagine (12 mM), aspartic acid (12 mM), glutamic acid (12 mM), proline (12 mM), and tryptophan (12 mM) in ultrapure water and mix well, and add the prepared amino acid additives into the basal culture medium at a volume ratio of 0.08%;
[0103] (4) Preparation of inorganic salt additives: manganese sulfate (0.1 mg / L), sodium silicate (150 mg / L), ammonium molybdate (1.5 mg / L), ammonium metavanadate (0.68 mg / L), nickel sulfate (0.2 mg / L), stannous chloride (0.3 mg / L), aluminum chloride (2.2 mg / L), silver nitrate (0.2 mg / L), barium acetate (3 mg / L), potassium bromide (0.15 mg / L), cadmium chloride (5 mg / L), cobalt chloride (4 mg / L), chromium chloride (0.5 mg / L), sodium fluoride (6 mg / L), potassium iodide (0.2 mg / L), germanium dioxide (0.8 mg / L), rubidium chloride (3 mg / L), and zirconium oxychloride (5 mg / L) were dissolved and mixed in ultrapure water, and the prepared inorganic salt additives were added to the basal culture medium at a volume ratio of 0.05%;
[0104] (5) Preparation of Chinese herbal medicine extract: Resveratrol (250 μM), tanshinone (60 μM), and magnolol (6 mM) were dissolved and mixed in DMSO, and the prepared Chinese herbal medicine extract was added into the basal culture medium at a volume ratio of 0.1%;
[0105] (6) The above-mentioned culture medium additives and Chinese herbal medicine extracts are mixed with 90% by volume of the basal culture medium (CSCs Basal) to complete the preparation. Among them, although the proportion of protein additives has reached 10%, in actual application, the proportion of other types of substances is relatively small and can be ignored when confirming the required volume in the system (i.e., the amount that can exert the effect).
[0106] The present invention enriches the ingredients of culture medium additives, wherein lipid additives are rich in lipid substances, which help to meet the formation and stability of cell membranes and vigorous lipid metabolism requirements in tumor stem cell spheres; protein additives are various protein factors that promote the increase of cell stemness (differentiation ability), which can regulate key pluripotency factors such as NANOG, SOX2 and OCT4 while regulating signal pathways such as MAPK and PI3K / Akt, which helps to support the enrichment and growth of tumor stem cells; amino acid additives contain various amino acids required for cell growth and division, which provide raw materials for synthesizing proteins, nucleic acids and other molecules for the formation of tumor stem cell spheres, regulate oxidative stress, and the secretion of key cytokines, which helps to promote the growth and maintenance of spheres; inorganic salt additives contain various ions in inorganic salts, and their addition is conducive to participating in signal communication between cells, helping to regulate the tumor microenvironment, and the adhesion and migration ability of tumor stem cells. The addition of traditional Chinese medicine extracts (TCMs) helps to inhibit the occurrence of oxidative stress and inflammatory reactions, improve the environment for the formation of tumor stem cell spheres, and promote the maintenance of their healthy state. In summary, the various additives contained in the present invention jointly promote the formation of tumor stem cell spheres by involving different mechanisms and pathways.
[0107] Example 2: Cultivation of lung tumor stem cell spheres
[0108] In this example, A549 human non-small cell lung cancer cell line (Mesenchymal cells, CTCC-001-0036) was selected as the culture object to obtain lung tumor stem cell spheres. Specifically, the initial seed plate density was 2×10 3 / mL, mixed with 3mL of the tumor stem cell sphere culture or culturing medium obtained in Example 1, cultured in a 6 cm cell culture dish, supplemented with 1mL of culture medium every 3 days, and photographed and observed until the end of the culture at the 15th day.
[0109] It was found that A549 tumor cells in suspension culture could spontaneously form tumor stem cell spheres through cell proliferation, which were evenly dispersed in the culture medium, without adhesion, dense and uniform morphology, small size differences, and appeared healthy. The middle part of the sphere did not show blackening or necrosis due to less oxygen exposure ( Figure 1 A), proving that the culture medium provided by the present invention has excellent effects in the cultivation or culture of tumor stem cell spheres.
[0110] Example 3: Characterization of lung tumor stem cell spheres
[0111] For the spheres formed in Example 2, further characterization experiments were performed. First, Figure 1The microscopic morphology shown in the figure shows that the lung cancer stem cell spheres formed have uniform morphology and size, dense structure, and obvious sphere characteristics. Afterwards, to further illustrate the effect of the present invention, for the difference in the characteristics of enriched lung tumor stem cells, the gene expression levels of the lung tumor cell spheres in the basic scheme and the optimized scheme of the culture medium were detected, including NANOG, OCT4, SOX2 and other pluripotency genes, CD166, CD133, CD90, CD44 and other specific surface protein-related genes, and characteristic genes CDH1, CDH2, SNAI1, SNAI2, ZEB1, ZEB2, TWIST, TNC, FN1, MMP2, etc. that mark the epithelial-mesenchymal transition EMT process. The primers designed in this embodiment are shown in SEQ ID NO.1-42 in Table 1, and are all commissioned to Thermo Fisher for synthesis.
[0112] Table 1 Primers and related sequences involved in the present invention
[0113]
[0114]
[0115] Table 2 The antibodies used in the present invention and their sources
[0116] Antibody Name Part Number company SOX2 3579S Cell Signaling NANOG 4903S Cell Signaling OCT4 2840S Cell Signaling
[0117] Figures 2 to 4 They are the detection results of the above genes in this embodiment. It can be seen from the results that after being cultured in a tumor stem cell sphere culture medium (i.e., the basic medium solution provided by the present invention), lung tumor stem cell spheres with high stemness level, high gene expression of lung cancer stem-specific marker proteins, and stronger invasion and migration ability can be obtained. Among them, the basic medium solution is sufficient to support the enrichment of lung tumor stem cell characteristic marker genes and the expression of lung tumor stem cell characteristics, and the optimized solution can further obtain better culture effects. Finally, the spheres in the optimized solution were immunofluorescently stained with antibodies to pluripotency proteins such as NANOG, OCT4, and SOX2. Figures 5 to 7 These are the immunofluorescence staining results of the above antibodies in this example, which indicate that tumor stem cell spheres can highly express these pluripotency-related proteins.
[0118] Example 4: Comparative study with reported culture protocols
[0119] To illustrate the high efficiency and specificity of the tumor stem cell sphere culture scheme in the present invention, it was compared with the culture scheme reported previously (Thakur R, Kumari N, Mishra DP. Isolation and characterization of cancer stem cells [M] / / Protocol Handbook for Cancer Biology. Academic Press, 2021: 87-105.) ( Figure 8 Two sets of ultra-low adsorption 6 cm dishes were prepared, and the culture medium of the present invention was added to one set. The other set was mixed in 3 mL of culture medium with EGF, FGF, BSA, and B27 components (commonly used key components for tumor stem cell sphere culture) as additives according to the same method as described above. 2×10 3 The cells were inoculated at a concentration of 100 / mL. After the same culture time, the tumor stem cell spheres cultured in the two groups of culture media showed obvious differences. The culture medium prepared according to one of the prior arts can only obtain lung cancer cell aggregates, which have no obvious sphere characteristics and have great heterogeneity ( Figure 8 B), while the tumor stem cell spheres obtained by culture in the medium provided by the present invention have uniform size, regular shape, and obvious homogeneity ( Figure 8 A).
[0120] Further analysis of the culture results and differences in culture medium components suggested that compared with previous reports (see Qiu X, Wang Z, Li Y, et al. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446 [J]. Cancer letters, 2012, 323 (2): 161-170.), this may be due to the addition of TVP (a combination of TGFβ1, VEGF and PDGF) in one of the optimization schemes of the present invention, which can specifically promote the enhancement of the stemness characteristics of the sphere by regulating signal pathways such as Wnt, Notch, and PI3k / Akt; the addition of lipid components such as myristic acid, oleic acid, palmitic acid, and linolenic acid can specifically enhance the fatty acid oxidation level of tumor cells and further regulate the high expression of stemness genes; the addition of various amino acids and inorganic salts and other components can meet the basic metabolism of the sphere while maintaining the stability of the microenvironment inside the tumor sphere; the addition of Chinese herbal medicine extract components can enhance the anti-inflammatory and antioxidant capabilities of the culture medium, improve the microenvironment around the cells, and prolong the optimal activity duration and culture time of the tumor stem cell sphere.
[0121] Based on the above speculation, further relevant verification and comparison experiments were carried out to illustrate the excellence and specificity of the culture scheme in the present invention. First, the expression of lung tumor stem cell characteristic genes was detected by real-time fluorescence quantitative PCR technology, and the results were compared with those in Example 2 ( Fig. 9 ), it can be seen that the scheme of the present invention promotes the enrichment of tumor stem cell characteristics by ten times or even nearly a hundred times. Then, the effects of the two culture schemes on the proliferation activity of the spheroids themselves were compared ( Fig.10 ), it can be seen that the proliferation capacity of the spheres in this culture scheme is much higher than that in the existing schemes.
[0122] Example 5: The key role of MOPL in the present invention
[0123] To further illustrate the indispensability of each component additive of the present invention, taking the presence or absence of a single component and a mixed component of MOPL (MOPL: a combination of myristic acid, oleic acid, palmitic acid, and linolenic acid) in the lipid additive (L Sup) as an example, an experiment was set up to explore the effect of + / -MOPL on the formation of lung tumor stem cell spheres, and the results are as follows.
[0124] First, the culture system lacks key fatty acid components such as MOPL, which will result in a smaller and fewer tumor spheres under the same conditions and fail to grow fully ( Fig.11 ); secondly, the Assay Genie (BA0184) fatty acid oxidation (FAO) fluorescence detection kit was used to detect the activity level of intracellular FAO ( Fig.12 ), the detection method refers to the kit instructions.
[0125] like Fig.12 As shown, the vertical axis refers to the cumulative level of fluorescently labeled fatty acids in tumor cells (excitation wavelength and emission wavelength are 488 and 523nm respectively). According to the detection principle of the kit, the stronger the FAO metabolic activity, the more fluorescent fatty acids will be absorbed and accumulated by the tumor cells themselves. It was found that the use of MOPL alone cannot maximize the promotion of FAO levels, and the optimal effect can only be achieved when these ingredients are used in combination.
[0126] Specifically, palmitic acid and oleic acid promote the FAO pathway mediated by the carnitine shuttle system; myristic acid and linolenic acid promote the formation of peroxisomes by promoting fatty acyl-CoA synthetase. Therefore, the combination of these ingredients promotes the activity of fatty acid oxidation through different pathways. The change in intracellular lipid metabolism activity, especially the increase in FAO levels, is conducive to the enhancement of the stemness of tumor cells.
[0127] Example 6: The key role of TVP in the present invention
[0128] To further illustrate the indispensability of the additive components of the present invention, an experiment was conducted to investigate the effect of + / - TVP on the formation of lung tumor stem cell spheres, taking the presence or absence of TVP (TVP: a combination of TGFβ1, VEGF, and PDGF) in protein additives as an example. The results are as follows.
[0129] First, the lack of TVP in the culture system will seriously weaken the three-dimensionality and compactness of spheroid formation ( Fig.13 ), the dryness of the earth will also weaken accordingly ( Fig.14 ), the lack of any of these factors would weaken the stemness of the spheroids and the expression of specific surface marker proteins, and the complete lack of TVP had the lowest level of stemness in the cultured cells.
[0130] Example 7: Detection of intracellular ROS levels
[0131] In order to illustrate the role of resveratrol, tanshinone and magnolol, three active ingredients extracted from traditional Chinese medicine, in the culture of tumor stem cell spheres and the advantages of the present invention, the traditional Chinese medicine extracts were prepared or mixed at preferred concentrations and added to the culture medium at preferred ratios, wherein the setting conditions are specifically as follows:
[0132] (1) Only 250 μM resveratrol was added
[0133] (2) Only 60 μM tanshinone was added
[0134] (3) Adding only 6 mM magnolol
[0135] (4) Mixed addition of the above three ingredients
[0136] In order to detect the anti-inflammatory and antioxidant effects of the aforementioned Chinese herbal extracts and their mixtures in the formation of tumor stem cell spheres, different conditions were set to detect the gene expression levels of inflammatory factors such as IL-6 and IL-1β ( Fig.15 ), and the intracellular ROS content was detected using an intracellular ROS detection kit (Abcam, ab186027) Fig.16 ), the detection method refers to the kit instructions.
[0137] From the comprehensive results, resveratrol, tanshinone and magnolol can indeed reduce the occurrence of inflammatory response and oxidative stress, and the effect of mixed addition of the three is most obvious, and they can be used for fixed combination culture of tumor stem cell sphere formation.
[0138] In summary, the culture medium for the cultivation or culture of tumor stem cell spheres provided by the present invention can promote the formation of cell spheres with obvious tumor stem cell characteristics in a specific and efficient manner, specifically including the enhancement of stemness characteristics that mark unlimited proliferation and differentiation ability; the increase in the expression of cancer cell-specific surface antigens; the strengthening of the EMT process that marks the invasion and metastasis ability of tumor cells. The addition of protein additives such as TVP and fatty acid elements such as MOPL shows its new application in promoting its stemness growth and promoting the expression of specific surface marker proteins during tumor stem cell culture. At the same time, the characteristic addition of several traditional Chinese medicine ingredients such as resveratrol, tanshinone and magnolol helps to reduce the production of adverse factors such as inflammatory factors and ROS during the formation of tumor stem cell spheres, providing a healthy growth environment, so that the cultured tumor stem cell spheres can maintain the best state in subsequent research or experiments, ensuring the efficiency of the experiment and the accuracy of the data. Therefore, the combination of the above-mentioned culture medium and culture scheme can provide a new case reference, practice and application for the current field of tumor stem cell research.
[0139] The specific embodiments described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A culture medium, preferably for culturing tumor stem cell spheres, characterized in that: The culture medium comprises TVP, MOPL, Chinese herbal medicine extracts, lipid additives, protein additives, amino acid additives and inorganic salt additives; Wherein, the TVP is a combination of transforming growth factor TGFβ1, vascular endothelial growth factor VEGF, and platelet-derived growth factor PDGF. The MOPL is a combination of myristic acid, oleic acid, palmitic acid and linolenic acid. The lipid additives include cholesterol and tocopherol acetate; The protein additives include bovine serum albumin, basic fibroblast growth factor bFGF, and epidermal growth factor EGF; The amino acid additives include glutamic acid, proline, and tryptophan; The inorganic salt additives include ammonium molybdate, stannous chloride, silver nitrate and potassium iodide.
2. The culture medium according to claim 1, wherein The volume ratio of the TVP to the culture medium is 3%-5%. In the TVP, The concentration of transforming growth factor TGFβ1 is 1-10 ng / mL, preferably 5-7 ng / mL; The concentration of vascular endothelial growth factor VEGF is 100-200 μg / mL, preferably 120-150 μg / mL; The concentration of platelet-derived growth factor PDGF is 40-80 μg / mL, preferably 50-65 μg / mL.
3. The culture medium according to claim 1, wherein The volume ratio of the MOPL to the culture medium is 0.008%-0.01%. In the MOPL, The concentration of myristic acid is 7-15 mg / L, preferably 8-12 mg / L; The concentration of oleic acid is 9-13 mg / L, preferably 10-12 mg / L; The concentration of palmitic acid is 8-15 mg / L, preferably 9-12 mg / L; The concentration of linolenic acid is 6-18 mg / L, preferably 8-14 mg / L.
4. The culture medium according to claim 1, wherein The volume ratio of the Chinese herbal medicine extract to the culture medium is 0.1%.
5. The culture medium according to claim 1 or 4, wherein The traditional Chinese medicine extract comprises resveratrol, tanshinone and magnolol.
6. The culture medium according to claim 5, wherein In the Chinese herbal medicine extract, The concentration of resveratrol is 10-1000 μM, preferably 200-500 μM; The tanshinone is 1-100 μM, preferably 50-80 μM; The concentration of magnolol is 3-10 mM, preferably 5-8 mM.
7. The culture medium according to claim 1, wherein The volume ratio of the lipid additive to the culture medium is 0.001%-0.01%, preferably 0.003%-0.005%; wherein the concentration of cholesterol is 200-300 mg / L (preferably 230-250 mg / L), and the concentration of tocopherol acetate is 50-100 mg / L (preferably 60-70 mg / L); The volume ratio of the protein additive to the culture medium is 2%-8%, preferably 3%-5%; wherein the concentration of bovine serum albumin is 200-350 mg / mL (preferably 240-270 mg / mL), the concentration of basic fibroblast growth factor bFGF is 3-7 mg / mL (preferably 4.8-6 mg / mL), and the concentration of epidermal growth factor EGF is 20-50 μg / mL (preferably 20-38 μg / mL); The volume ratio of the amino acid additive to the culture medium is 0.02%-0.2%, preferably 0.08%-0.12%; wherein the concentration of glutamic acid is 5-20mM (preferably 8-12mM), the concentration of proline is 5-20mM (preferably 8-12mM), and the concentration of tryptophan is 5-20mM (preferably 8-12mM); The volume ratio of the inorganic salt additive to the culture medium is 0.05%-0.08%, preferably 0.05%-0.4%; wherein the concentration of ammonium molybdate is 0.2-2 mg / L (preferably 1-1.5 mg / L), the concentration of stannous chloride is 0.05-0.8 mg / L (preferably 0.1-0.3 mg / L), the concentration of silver nitrate is 0.03-0.39 mg / L (preferably 0.08-0.2 mg / L), and the concentration of potassium iodide is 0.05-0.9 mg / L (preferably 0.05-0.2 mg / L).
8. The culture medium according to claims 1-7, wherein: (1) The lipid additive further comprises: one or more selected from the group consisting of arachidonic acid (1-6 mg / L, preferably 2-4 mg / L), linoleic acid (7-15 mg / L, preferably 9-12 mg / L), and stearic acid (4-13 mg / L, preferably 10-12 mg / L); (2) The protein additive further comprises: a combination of one or more selected from reduced glutathione (0.005-0.05 mg / mL, preferably 0.01-0.03 mg / mL), insulin (0.5-0.8 mg / mL, preferably 0.1-0.3 mg / mL), and transferrin (50-100 μg / mL, preferably 50-70 μg / mL); (3) The amino acid additive further comprises: a combination of one or more selected from glycine (5-20 mM, preferably 8-12 mM), alanine (5-20 mM, preferably 8-12 mM), asparagine (5-20 mM, preferably 8-12 mM), and aspartic acid (5-20 mM, preferably 8-12 mM); and / or (4) The inorganic salt additives also include: manganese sulfate (0.05-0.5 mg / L, preferably 0.1-0.2 mg / L), sodium silicate (100-180 mg / L, preferably 120-150 mg / L), ammonium metavanadate (0.1-1 mg / L, preferably 0.4-0.68 mg / L), nickel sulfate (0.05-1 mg / L, preferably 0.1-0.2 mg / L), aluminum chloride (0.5-3 mg / L, preferably 1-2.2 mg / L), barium acetate (1-5 mg / L, preferably 2-3 mg / L), potassium bromide (0.01-1 mg / L, preferably 0.1-0.2 mg / L), Preferably, the present invention comprises one or more combinations of 0.05-0.15 mg / L), cadmium chloride (2-10 mg / L, preferably 2-5 mg / L), cobalt chloride (1-7 mg / L, preferably 2-4 mg / L), chromium chloride (0.1-1 mg / L, preferably 0.2-0.5 mg / L), sodium fluoride (3-10 mg / L, preferably 4-6 mg / L), germanium dioxide (0.2-1 mg / L, preferably 0.4-0.8 mg / L), rubidium chloride (0.5-5 mg / L, preferably 1-3 mg / L), and zirconium oxychloride (2-10 mg / L, preferably 2-5 mg / L).
9. The culture medium according to claim 1, further comprising DMEM / F12 as a basal culture medium, wherein the volume ratio of DMEM / F12 to the culture medium is 70%-90%, preferably 90%.
10. A method for culturing tumor stem cell spheres, characterized in that: The method uses the culture medium described in claims 1-9 to culture tumor stem cells and / or tumor stem cell spheres.
